| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |